Global Sodium Iodide I-131 Kits and Capsules Market Strategic Research Report

Scope of the Report

The global Sodium Iodide I-131 Kits and Capsules market size is predicted to grow from US$ 319 million in 2025 to US$ 719 million in 2032; it is expected to grow at a CAGR of 12.5% from 2026 to 2032.

Sodium Iodide I-131 is a radioactive isotope of iodine used for diagnostic imaging and therapeutic nuclear medicine applications, primarily targeting the thyroid gland. It exploits the fact that the thyroid avidly absorbs iodine to deliver precise radioactive treatment or imaging contrast.

Cancer is the second leading cause of death in the world, and its number of deaths and cases is increasing year by year. At the same time, based on the unparalleled advantages of nuclear medicine in precision treatment and integrated tumor diagnosis and treatment, the demand for radionuclide drugs and nuclear medicine examinations is expected to increase year by year. The demand for sodium iodide [131I] capsules and solutions has also increased, mainly including diseases such as thyroid tumors and hyperthyroidism.

Governments in many countries are encouraging and supporting innovation and development in the medical industry, including research on nuclear medicine and radiopharmaceuticals, which provides policy support for the development of the sodium iodide [131I] capsule and solution market.

With the advancement of research and development and production technology of radiopharmaceuticals, more effective and safer sodium iodide [131I] capsules and solutions have been produced, thus promoting the development of the industry.

The use of radiopharmaceuticals is subject to strict regulations and supervision. Failure to comply with regulations may lead to product recalls or market access barriers, thus affecting market development.

The public's understanding of radiopharmaceuticals is insufficient, and some patients may have doubts or concerns about radiotherapy, which may affect the market demand for sodium iodide I-131 drugs.

The safety of radiopharmaceuticals is a key factor in the development of the market, and any safety accidents or leaks may have a negative impact on the industry's image and the market.

With the continuous advancement of science and technology, new production technologies and processes will be introduced into the industry. These new technologies can improve product quality, increase production efficiency, and reduce costs.

Many countries are reforming their healthcare systems to provide better medical services and more effective treatments. This reform is expected to promote the use of sodium iodide [131I] capsules and solutions and bring more opportunities to the industry.

Global cooperation and competition will have an impact on the development of the industry. Cooperation between manufacturers, suppliers, and research institutions in different countries and regions helps promote technological innovation and market expansion, but there is also fierce competition.

This report presents a comprehensive overview of the global Sodium Iodide I-131 Kits and Capsules market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Capsule
• Solution

Segment by players, this report covers

• International Isotopes Inc
• CNNC
• DC Pharma
• Curium Pharma
• Jubilant Pharmova
• PDRadiopharma
• ANSTO
• POLATOM（NCBJ）
• NTP Radioisotopes
• Isotope JSC (Rosatom)
• Institute of Isotopes Co. Ltd.
• JRTR

Segment by Application

• Hyperthyroidism Treatment
• Thyroid Cancer Treatment

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Sodium Iodide I-131 Kits and Capsules market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Hyperthyroidism Treatment, Thyroid Cancer Treatment evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact